Mesa Laboratories Inc (MLAB)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -249,443 | -245,651 | -250,309 | -254,246 | 948 | -717 | 1,819 | 930 | -1,465 | -3,976 | -1,562 | 1,871 | 7,575 | 5,093 | 4,052 | 3,082 | -2,518 | -2,606 | -2,223 | 1,349 |
| Total stockholders’ equity | US$ in thousands | 155,214 | 161,451 | 150,727 | 145,393 | 402,961 | 387,759 | 387,719 | 393,480 | 387,205 | 374,236 | 380,431 | 393,801 | 396,329 | 399,417 | 399,003 | 406,227 | 412,795 | 392,412 | 382,234 | 220,013 |
| ROE | -160.71% | -152.15% | -166.07% | -174.87% | 0.24% | -0.18% | 0.47% | 0.24% | -0.38% | -1.06% | -0.41% | 0.48% | 1.91% | 1.28% | 1.02% | 0.76% | -0.61% | -0.66% | -0.58% | 0.61% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-249,443K ÷ $155,214K
= -160.71%
Mesa Laboratories Inc's return on equity (ROE) has shown fluctuations over the past few years. The ROE was relatively low in the first half of 2020, with negative values indicating that the company was generating net losses relative to shareholders' equity.
However, the ROE started to improve in March 2021, reaching positive values and showing a steady increase through the end of 2021. This improvement indicated a better utilization of shareholders' equity to generate profits.
In the following quarters of 2022, the ROE fluctuated, with some periods showing negative values again, suggesting challenges in profitability and efficiency in utilizing equity. The negative values in the last quarter of 2023 and through 2024 were particularly significant, with ROE dropping to extremely low negative percentages.
The significant negative ROE percentages in the last quarters of 2023 and 2024 can be concerning as they indicate that the company's profitability may have significantly decreased, or potentially even turned negative.
Overall, it is essential for Mesa Laboratories Inc to focus on improving its profitability and operational efficiency to enhance its ROE performance and provide better returns to its shareholders in the future.
Peer comparison
Dec 31, 2024